Skip to content
value.today

Tyme Technologies

TYMEUnlisted company
$105 Mlast known market cap, Jan 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
Dec-2020 ending year
value.today research
Net income
$-29 M
value.today research
Employees
—

Tyme Technologies in brief

Tyme Technologies is an unlisted company in the Biotechnology industry, based in New Jersey, USA. It was founded in 2011. In the year to Dec 2020 it had sales of $0 M and a net loss of $29 M.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Tyme Technologies timeline

1 events, 2011
  1. 2011
  2. 🏁
    · approximate
    Founded

Events of Tyme Technologies from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Tyme Technologies

Acquisitions and changes
No longer listed: it is not in the SEC's, Nasdaq Trader's and FINRA's lists of US-traded securities (checked 14 November 2026).

Market cap history

$0 M$50 M$100 M$150 M$200 M202020212022

World rank over time

▼ down 5,941 places since 2020
2020-01-01: #16239#16,23920202021-01-01: #16630#16,63020212022-01-07: #22180#22,1802022

Rank in USA: #3,297 (Jan 2020) · #3,443 (Jan 2021) · #4,373 (Jan 2022)

Annual results

Revenue
$0 M
Operating income
—
Net income
$-29 M

Dec-2020 ending year

Lobbying by Tyme Technologies#

$200 K spent on lobbying the US Congress and federal agencies in 2020, most often on health issues.

Lobbying, 2020
$200 K
#761 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2020
2026 so far
—
  • Health Issues4 reports

Lobbying firms hired in 2020

Baker & Hostetler LLP $200 K

Tyme Technologies: lobbying spending by year
YearSpendingOwn lobbyistsReports
2020$200 K—4

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Tyme Technologies, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

How Tyme Technologies compares in Biotechnology

  • Revenue$0 M · higher than 0% of 647

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Tyme Technologies🇺🇸$105 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 7, 2022 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Tyme Technologies? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Tyme Technologies's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Tyme Technologies? Suggest a correction